γ-Hydroxybutyric acid

γ-Hydroxybutyric acid
Clinical data
Other namesGHB, γ-hydroxybutyrate, oxybate
Addiction
liability
High
Routes of
administration
By mouth, intravenous
Drug classGHB receptor agonist;
GABAB receptor agonist;
Depressant;
Hypnotic;
Sedative
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability25% (oral)
Metabolism95–98%, mainly liver, also in blood and tissues
MetabolitesSuccinic semialdehyde, Succinic acid
Onset of actionWithin 5–15 minutes
Elimination half-life30–60 minutes
Excretion1–5%, kidney
Identifiers
  • 4-hydroxybutanoic acid
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.218.519
Chemical and physical data
FormulaC4H8O3
Molar mass104.105 g·mol−1
3D model (JSmol)
  • O=C(O)CCCO
  • InChI=1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7) checkY
  • Key:SJZRECIVHVDYJC-UHFFFAOYSA-N checkY
  (verify)

γ-Hydroxybutyric acid (GHB), also known as 4-hydroxybutanoic acid, is a naturally occurring neurotransmitter and a depressant drug. It is a precursor to GABA, glutamate, and glycine in certain brain areas. It acts on the GHB receptor and is a weak agonist at the GABAB receptor. GHB has been used in medicine as a general anesthetic and as treatment for cataplexy, narcolepsy, and alcohol use disorder. It is also used illicitly for performance enhancement, date rape, and recreation.

It is commonly used in the form of a salt, with the conjugate base of GHB being called γ-hydroxybutyrate or oxybate. The sodium (NaGHB, sodium oxybate, or Xyrem) and potassium (KGHB, potassium oxybate) salts are common. GHB is produced as a result of fermentation, and is found in small quantities in some beers and wines, beef, and small citrus fruits.

Succinic semialdehyde dehydrogenase deficiency causes GHB to accumulate in the blood.